Kyrgyzstan Medical Device Advertising and Circulation Control: Labeling Consistency and Distribution Inspections

1. Key takeaways

The scope of Law No. 216 in Kyrgyzstan covers the entire chain from the definition of a device to its distribution, and expressly includes labeling and advertising. Together with Cabinet Resolution No. 450 (June 29, 2026), which extends inspections into the distribution stage, and the reference to marking and packaging requirements in the title of Cabinet Resolution No. 513, this forms a complete supervisory structure: before market entry, labeling content is controlled; during the marketing life, advertising claims are controlled; after market entry, consistency in distribution is controlled. All three stages draw on the same registration dossier.

2. Legal basis

1. Law of the Kyrgyz Republic on the Circulation of Medical Devices, Law No. 216 of December 29, 2023: the scope of the law covers the definition of devices, their circulation, labeling and advertising, import and prohibited import.
2. Cabinet Resolution No. 513, August 27, 2024: the title of the resolution includes requirements for the marking and packaging of medical devices; Article 2(2) makes a cross-reference to Decision No. 27 (whose title includes requirements for their marking and operating documentation, with the exception of item 63).
3. Cabinet Resolution No. 450, June 29, 2026: procedures for inspections in the field of medical device circulation.
4. Article 3 of Law No. 216: the definition of an adverse event includes insufficiency or incorrectness of accompanying information (documentation).
5. Articles 29 and 31 of Law No. 216: import and prohibited import.

Source note: the detailed rules on advertising (approval requirements, prohibited claims, media restrictions) were not available this round in official wording suitable for verbatim citation. The following is framed at the level of principles; specific application must follow the current legislation.

3. Expert insights

Insight one: labeling and advertising are mentioned side by side in the law, and this is no accident.

Law No. 216 regulates labeling and advertising within the same statute. What they share is that both are outward-facing expressions of product information. Placing them together carries a practical implication: the product name, model, intended purpose and performance claims used in advertising must remain consistent with the label, the instructions for use and the registration dossier. Inconsistency among the three is the problem most easily detected in distribution oversight.

Insight two: advertising claims that exceed the scope of registration are the most common compliance risk.

Typical situations include: claiming indications not recorded in the registration dossier, using absolute formulations such as best or only, citing certifications that have not been obtained, and using performance data inconsistent with the instructions for use in promotional materials. We recommend that companies establish a pre-publication review mechanism for advertising content, with the intended purpose and performance parameters in the registration dossier as the review benchmark.

Insight three: distribution consistency inspections have three main points of leverage.

Cabinet Resolution No. 450 extends inspections into the distribution stage. Judging from the verified rules, the main levers are three:

• whether the product has a registered identity: the registration certificate and the national register records;
• whether the label is consistent with the dossier: authorized representative information, registration number, model list, expiry date;
• whether the operator is qualified: distribution licensing (see article 39 of this series).

All three point to the same registration dossier.

Insight four: an error in accompanying information may simultaneously constitute an advertising violation and an adverse event.

As discussed in article 42 of this series, the definition of an adverse event in Law No. 216 includes insufficiency or incorrectness of accompanying information (documentation). This means that an instructions-for-use document containing errors may be a violation at the advertising and labeling level and may also constitute a reportable adverse event. We recommend bringing instructions for use and promotional materials into a single review process rather than managing them separately.

Insight five: language issues are amplified in the advertising context.

As discussed in articles 09 and 30 of this series, language requirements apply to documentation. Advertising addresses the public, so language issues are more sensitive than in technical files — promotional materials aimed at users that exist only in a foreign language not only fail the language requirements but may also be viewed as incomplete information. We recommend preparing promotional materials in Russian and/or Kyrgyz as well, following the language position confirmed in writing.

4. Practical recommendations

First, establish a pre-publication review mechanism for advertising content. We recommend using the registration dossier as the review benchmark and checking item by item: product name and model, intended purpose, performance parameters, references to certifications and approvals, and absolute formulations. Retain the review records.

Second, bring instructions for use and promotional materials into one review process. We recommend adding a checkpoint to the review list: are the claims in the material consistent with the instructions for use? If not, send it back for revision.

Third, prepare promotional materials in the confirmed language position. We recommend having the authorized representative confirm the language requirements in writing, then preparing all promotional materials uniformly, avoiding a mix of versions.

Fourth, prepare a labeling consistency self-check sheet for distribution inspections. We recommend checking item by item: is the authorized representative information current, is the registration number displayed, does the model fall within the registered list, and is the expiry date marked in a way that is easy to calculate.

Fifth, bring material changes into change management. We recommend specifying in the change management procedure that major revisions of promotional materials — especially those involving intended purpose and performance parameters — must be assessed for their impact on the registration dossier.

5. Verification checklist

• □ A pre-publication review mechanism for advertising content is in place, using the registration dossier as the benchmark, with review records retained;
• □ Instructions for use and promotional materials have been brought into a single review process to check consistency of claims;
• □ Promotional materials have been prepared in the language position confirmed in writing;
• □ A labeling consistency self-check sheet has been prepared: authorized representative information, registration number, model list, expiry date marking method;
• □ Major revisions of promotional materials are subject to change management, with assessment of the impact on the registration dossier;
• □ The current text of Law No. 216 on labeling and advertising has been obtained to verify specific requirements.

Regulatory information verified as of October 29, 2026.

Our services cover pre-market pathway selection and feasibility assessment, registration dossier preparation and submission, authorized representative arrangements, local testing and clinical trial organization, manufacturing site inspection coordination, quality management system conformity support, post-market surveillance and vigilance system setup, import and distribution compliance, and fee calculation and project budget management.

The GRZAN regulatory team consists of professionals with many years of hands-on experience in Eurasian Economic Union registrations and has built stable local cooperation networks in Bishkek, Almaty, Tashkent and Moscow. Working in Chinese, Russian and English, we deliver actionable solutions for foreign manufacturers on the key issues commonly encountered in CIS markets, including authorized representative arrangements, notarization and legalization chains for powers of attorney, localization of technical documentation, and inspection readiness.

We hold to one principle: every regulatory conclusion we publish must be traceable to verifiable official sources; figures and timelines that cannot be verified are always marked as practical estimates and are never presented as legal requirements drawn from experience.

GRZAN provides registration and compliance support in this country for manufacturers, importers and authorized representatives. For project inquiries on market access in Kyrgyzstan or the Eurasian Economic Union, please contact us at info@grzanglobal.com.

GRZAN | Global Regulatory Registration and Compliance Services for Medical Devices